Corbus Pharmaceuticals Holdings Inc.
Organization details
- Legal name
- Corbus Pharmaceuticals Holdings Inc.
- Former names
- SAV Acquisition Corp
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Norwood
- Headquarters state / province
- Massachusetts
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- CRBP
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001595097
- EIN
- 46-4348039
Board of directors
-
Alan F. Holmer · DirectorSince 2023
-
Anne Altmeyer · DirectorSince 2023
-
Avery W. Catlin · DirectorSince 2023
-
Brent Pfeiffenberger · DirectorSince 2026
-
John Kenneth Jenkins · DirectorSince 2023
-
Peter Salzmann · DirectorSince 2023
-
Rachelle Suzanne Jacques · DirectorSince 2023
-
Winston Kung · DirectorSince 2024
-
Yong Ben · DirectorSince 2023
-
Yuval Cohen · Director · Chief Executive OfficerSince 2023
Chief executives
Director election results
Annual meeting of May 13, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
95.5%
-
95.7%
-
95.8%
-
99.1%
-
99.1%
-
99.2%
Board connections
4 of this board's directors also sit on 6 other boards. 6 are in the same sector.
-
Akari Therapeutics plc Same sectorvia Rachelle Suzanne Jacques
-
Butterfly Network Inc. Same sectorvia Brent Pfeiffenberger
-
Century Therapeutics Inc. Same sectorvia Brent Pfeiffenberger
-
Immunovant Inc. Same sectorvia Peter Salzmann
-
Janux Therapeutics Inc. Same sectorvia Winston Kung
-
uniQure N.V. Same sectorvia Rachelle Suzanne Jacques
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $126,243
- 3 purchases by 1 insider
- Sold, last 12 months
- $2,715,419
- 14 sales by 10 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 29, 2026 | Cormorant Asset Management, LP Former 10% Owner | Open-market sale | −425,000 | $4.10 | $1,742,755 |
| Sep 14, 2026 | Yong Ben Director | Open-market sale | −2,000 | $7.84 | $15,680 |
| Aug 16, 2026 | Nicacio Leonardo Viana Officer (Chief Medical Officer) | Grant or award | +58,333 | — | — |
| Aug 11, 2026 | Saxena Nishant C Officer (Chief Business Officer) | Open-market purchase | +2,600 | $9.63 | $25,038 |
| Aug 7, 2026 | Yuval Cohen Director, Officer (Chief Executive Officer) | Open-market sale | −17,000 | $10.08 | $171,360 |
| Aug 7, 2026 | Moran Sean F. Officer (Chief Financial Officer) | Open-market sale | −12,000 | $10.08 | $120,960 |
| Jun 10, 2026 | Winston Kung Director | Open-market sale | −2,026 | $7.91 | $16,026 |
| Jun 10, 2026 | John Kenneth Jenkins Director | Open-market sale | −4,800 | $7.91 | $37,968 |
| Jun 10, 2026 | Anne Altmeyer Director | Open-market sale | −2,412 | $7.91 | $19,079 |
| Jun 3, 2026 | Saxena Nishant C Officer (Chief Business Officer) | Open-market purchase | +9,000 | $7.58 | $68,220 |
| Jun 2, 2026 | Saxena Nishant C Officer (Chief Business Officer) | Open-market purchase | +4,500 | $7.33 | $32,985 |
| May 21, 2026 | Saxena Nishant C Officer (Chief Business Officer) | Grant or award | +58,300 | — | — |
| May 19, 2026 | Winston Kung Director | Grant or award | +3,800 | — | — |
| May 19, 2026 | Rachelle Suzanne Jacques Director | Grant or award | +3,800 | — | — |
| May 19, 2026 | John Kenneth Jenkins Director | Grant or award | +3,800 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Corbus Pharmaceuticals Holdings Inc.
Who is the CEO of Corbus Pharmaceuticals Holdings Inc.?
Yuval Cohen is Corbus Pharmaceuticals Holdings Inc.'s Chief Executive Officer.
How many directors are on Corbus Pharmaceuticals Holdings Inc.'s board?
Corbus Pharmaceuticals Holdings Inc.'s board has 10 directors: Alan F. Holmer, Anne Altmeyer, Avery W. Catlin, Brent Pfeiffenberger, John Kenneth Jenkins, Peter Salzmann, Rachelle Suzanne Jacques, Winston Kung, Yong Ben and Yuval Cohen.
Are Corbus Pharmaceuticals Holdings Inc. insiders buying or selling shares?
Over the last 12 months, Corbus Pharmaceuticals Holdings Inc. insiders bought $126,243 of shares in 3 purchases and sold $2.7 million of shares in 14 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="corbus-pharmaceuticals-holdings-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.